tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

BGNE Stock Latest News

BGNE Upcoming Earnings Report: What to Expect?
Pre-EarningsBGNE Upcoming Earnings Report: What to Expect?
1M ago
BGNE
MapKure, SpringWorks, BeiGene present data from Phase 1a/1b study of BGB-3245
The FlyMapKure, SpringWorks, BeiGene present data from Phase 1a/1b study of BGB-3245
2M ago
BGNE
SWTX
FDA resuming China lab inspections could benefit Amicus, BeiGene, Barron’s says
The FlyFDA resuming China lab inspections could benefit Amicus, BeiGene, Barron’s says
2M ago
BGNE
CHRS
BeiGene opens office in Sao Paulo
The FlyBeiGene opens office in Sao Paulo
2M ago
BGNE
Enlivex, BeiGene enter clinical collaboration agreement
The FlyEnlivex, BeiGene enter clinical collaboration agreement
2M ago
BGNE
ENLV
BeiGene price target raised to $263.30 from $230.10 at BofA
The FlyBeiGene price target raised to $263.30 from $230.10 at BofA
2M ago
BGNE
Enlivex Therapeutics provides business updates on clinical programs
The FlyEnlivex Therapeutics provides business updates on clinical programs
2M ago
BGNE
ENLV
Enlivex, BeiGene collaborate to evaluate Allocetra with Tislelizumab
The FlyEnlivex, BeiGene collaborate to evaluate Allocetra with Tislelizumab
2M ago
BGNE
ENLV
J.P. Morgan Analysts Say These 2 Stocks Are Their Top Picks for 2023
Stock Analysis & IdeasJ.P. Morgan Analysts Say These 2 Stocks Are Their Top Picks for 2023
3M ago
BGNE
TRGP
5 Best Healthcare Stocks to Invest in Now, According to Analysts
Stock Analysis & Ideas5 Best Healthcare Stocks to Invest in Now, According to Analysts
3M ago
DHR
UNH
BeiGene enters new phase to expand U.S. R&D capacity in NJ
The FlyBeiGene enters new phase to expand U.S. R&D capacity in NJ
3M ago
BGNE
Leap Therapeutics news ‘disappointing at first glance,’ says Piper Sandler
The FlyLeap Therapeutics news ‘disappointing at first glance,’ says Piper Sandler
3M ago
BGNE
LPTX
Leap Therapeutics price target lowered to $2 from $3 at Mizuho
The FlyLeap Therapeutics price target lowered to $2 from $3 at Mizuho
3M ago
BGNE
LPTX
Leap Therapeutics provides update on BeiGene option agreement for DKN-01
The FlyLeap Therapeutics provides update on BeiGene option agreement for DKN-01
3M ago
BGNE
LPTX
Prelude Therapeutics, BeiGene enter clinical trial collaboration
The FlyPrelude Therapeutics, BeiGene enter clinical trial collaboration
3M ago
BGNE
PRLD
BeiGene price target raised to $262 from $213 at Cowen
The FlyBeiGene price target raised to $262 from $213 at Cowen
3M ago
BGNE
BeiGene reports Q4 EPS ($4.29), consensus ($5.40)
The FlyBeiGene reports Q4 EPS ($4.29), consensus ($5.40)
3M ago
BGNE
BeiGene announces China NMPA approval for tislelizumab
The FlyBeiGene announces China NMPA approval for tislelizumab
4M ago
BGNE
Immix Biopharma doses first two patients in Phase 1b/2a combination trial
The FlyImmix Biopharma doses first two patients in Phase 1b/2a combination trial
4M ago
NVS
BGNE
BeiGene price target raised to $350 from $290 at Guggenheim
The FlyBeiGene price target raised to $350 from $290 at Guggenheim
5M ago
BGNE
BeiGene announces FDA approval of Brukinsa for CLL
The FlyBeiGene announces FDA approval of Brukinsa for CLL
5M ago
BGNE
BeiGene announces MHRA granted marketing authorization for BRUKINSA
The FlyBeiGene announces MHRA granted marketing authorization for BRUKINSA
5M ago
BGNE